Article Details

Ambys Medicines garners $140 million to develop chronic liver disease treatments

Retrieved on: 2018-08-09 22:21:54

Tags for this article:

Click the tags to see associated articles and topics

Ambys Medicines garners $140 million to develop chronic liver disease treatments. View article details on hiswai:

Excerpt

<div>... with a $60 million Series A funding round led by Boston-based <b>Third Rock</b> <b>Ventures</b> and Japanese drugmaker Takeda Pharmaceutical Co. A further ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up